Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Cut by Northcape Capital Pty Ltd

Northcape Capital Pty Ltd trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 37.7% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,119 shares of the medical equipment provider’s stock after selling 676 shares during the quarter. Northcape Capital Pty Ltd’s holdings in Intuitive Surgical were worth $550,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. One Wealth Management Investment & Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares during the period. Daymark Wealth Partners LLC boosted its position in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after purchasing an additional 24 shares in the last quarter. Indiana Trust & Investment Management CO boosted its position in shares of Intuitive Surgical by 5.3% during the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 25 shares in the last quarter. Hoxton Planning & Management LLC boosted its position in shares of Intuitive Surgical by 4.9% during the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after purchasing an additional 25 shares in the last quarter. Finally, True North Advisors LLC boosted its position in shares of Intuitive Surgical by 2.1% during the 3rd quarter. True North Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $605,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Mark Brosius sold 2,115 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares in the company, valued at approximately $145,113.45. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock valued at $25,528,753 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 0.2 %

Shares of NASDAQ:ISRG traded up $0.94 during trading on Friday, reaching $484.78. The stock had a trading volume of 1,170,154 shares, compared to its average volume of 1,469,034. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.48. The firm has a market capitalization of $172.27 billion, a price-to-earnings ratio of 83.30, a P/E/G ratio of 5.40 and a beta of 1.39. The stock has a fifty day simple moving average of $480.34 and a two-hundred day simple moving average of $434.94.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the firm posted $1.18 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday. Barclays raised their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Finally, Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $458.35.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.